Last reviewed · How we verify
NCT04653285: FaST-PD-III
Facilitating Motor Skill Learning in Parkinson's Disease III
NA trial testing motor skill practice in Parkinson Disease in 24 participants. Completed in 15 April 2024.
8 April 2024
Quick facts
| Lead sponsor | University of Erlangen-Nürnberg |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 24 |
| Start date | 1 July 2022 |
| Primary completion | 8 April 2024 |
| Estimated completion | 15 April 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- motor skill practice
- aerobic exercise — full drug profile →
- rest
Conditions studied
- Parkinson Disease — all drugs for Parkinson Disease →
Sponsor
University of Erlangen-Nürnberg
Who can join
Adults 18 to 85, any sex, with Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is designed to assess the effects of cardiovascular (aerobic) exercise on motor skill learning in Parkinson patients. Specifically, the investigators examine whether moderate-intense aerobic exercise, performed immediately following motor skill practice over the course of a six week intervention period, facilitates motor memory consolidation. In this experimental trial, participants will be randomly allocated to either an intervention group (motor skill practice + aerobic exercise) or control group (motor skill practice + seated rest).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Cardiovascular exercise enhances motor learning across multiple sessions in people with Parkinson's disease: a randomized controlled pilot trial.
Wanner P, Frisch N, Rikus S, Roig M, et al · · 2025 · PMID 41436797 · DOI 10.1038/s41539-025-00391-6
Verify or expand the search:
- PubMed search for NCT04653285
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Parkinson Disease
Currently open trials in the same condition.
- NCT07399496 — Accelerated TMS for Apathy in PD · NA · recruiting
- NCT07371338 — Phase 1 Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of IPS101A in Parkinson's Disease Patients · Phase 1 · recruiting
- NCT07442370 — The Effect of Functional Rotational Exercises on Fall Risk and Mobility in Parkinson's Disease Patients · NA · recruiting
- NCT06848205 — Percept Transitions in FOG and PD · NA · recruiting
- NCT07432958 — A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (P · Phase 2 · recruiting
Other University of Erlangen-Nürnberg trials
Trials by the same sponsor.
- NCT05817396 — Dissemination of Physical Activity-related Health Competence in Vocational Education of Nursing Care · NA · unknown
- NCT05081258 — Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip Palate · NA · recruiting
- NCT04598633 — Influence of Probiotics on Clinical Parameters, the Oral Microbiome and the Immune System During an Orthodontic Treatmen · NA · unknown
- NCT04606186 — Influence of Probiotics on Clinical Parameters, the Oral Microbiome and the Immune System During an Orthodontic Treatmen · NA · unknown
- NCT04367389 — Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04653285 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Erlangen-Nürnberg
- Last refreshed: 10 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04653285.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing